Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avidity Biosciences, Inc.

26.66
+0.90003.49%
Post-market: 26.660.00000.00%17:37 EDT
Volume:1.53M
Turnover:40.57M
Market Cap:3.20B
PE:-9.23
High:27.02
Open:25.77
Low:25.66
Close:25.76
Loading ...
Dec 21, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2020

Major Issues Report

8-K - Current report
Aug 11, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2020

Major Issues Report

8-K - Current report
Jul 27, 2020

Major Issues Report

8-K - Current report
Jul 10, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 26, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 22, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 19, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 16, 2020

Major Issues Report

8-K - Current report
Jun 12, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 11, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 11, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 09, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jun 09, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jun 08, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 26, 2020

Correspondence

CORRESP [Cover] - Correspondence
May 22, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Feb 12, 2015

Report of foreign issuer